Perumal Yogeeswari Selected Research

DNA Gyrase

2/2016	Development of acridine derivatives as selective Mycobacterium tuberculosis DNA gyrase inhibitors.
3/2015	Novel amide and sulphonamide derivatives of 6-(piperazin-1-yl)phenanthridine as potent Mycobacterium tuberculosis H37Rv inhibitors.
3/2008	Synthesis and antimycobacterial evaluation of newer 1-cyclopropyl-1,4-dihydro-6-fluoro-7-(substituted secondary amino)-8-methoxy-5-(sub)-4-oxoquinoline-3-carboxylic acids.
2/2008	Novel ofloxacin derivatives: synthesis, antimycobacterial and toxicological evaluation.
6/2006	Gatifloxacin derivatives: synthesis, antimycobacterial activities, and inhibition of Mycobacterium tuberculosis DNA gyrase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Perumal Yogeeswari Research Topics

Disease

25	Tuberculosis (Tuberculoses) 12/2016 - 08/2004
10	Neuralgia (Stump Neuralgia) 10/2015 - 05/2007
9	Neoplasms (Cancer) 01/2022 - 10/2005
7	Infections 02/2015 - 10/2005
7	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2010 - 06/2006
6	Cardiotoxicity 02/2016 - 03/2014
5	Acquired Immunodeficiency Syndrome (AIDS) 10/2005 - 03/2004
4	AIDS-Related Opportunistic Infections 10/2005 - 11/2004
3	Inflammation (Inflammations) 03/2018 - 10/2015
3	Breast Neoplasms (Breast Cancer) 05/2016 - 05/2012
3	Pain (Aches) 11/2015 - 05/2006
3	Epilepsy (Aura) 08/2009 - 05/2007
2	Glioblastoma (Glioblastoma Multiforme) 03/2018 - 03/2016
2	Prostatic Neoplasms (Prostate Cancer) 01/2016 - 10/2015
2	Nervous System Diseases (Neurological Disorders) 10/2015 - 05/2007
2	Diabetes Complications 10/2014 - 05/2013
2	Central Nervous System Diseases (CNS Diseases) 08/2009 - 01/2006
2	Seizures (Absence Seizure) 01/2007 - 05/2006
2	Opportunistic Infections (Opportunistic Infection) 05/2005 - 11/2004
2	Bacterial Infections (Bacterial Infection) 05/2005 - 11/2004
1	Mouth Neoplasms (Oral Cancer) 01/2022
1	Oropharyngeal Neoplasms 01/2022
1	Hyperalgesia 08/2021
1	Autistic Disorder (Autism) 01/2019
1	Body Weight Changes 01/2017
1	Multiple Sclerosis 01/2017
1	Triple Negative Breast Neoplasms 05/2016
1	Rheumatoid Arthritis 01/2016
1	Extensively Drug-Resistant Tuberculosis 01/2016
1	Latent Tuberculosis 12/2015
1	Neuroblastoma 10/2015

Drug/Important Bio-Agent (IBA)

14	Pharmaceutical PreparationsIBA 01/2017 - 01/2006
6	AgarIBA 01/2010 - 08/2006
5	DNA GyraseIBA 02/2016 - 06/2006
5	EnzymesIBA 10/2015 - 08/2009
5	gamma-Aminobutyric Acid (GABA)IBA 01/2015 - 01/2006
4	Sirtuin 1IBA 01/2016 - 05/2012
4	Ether (Diethyl Ether)IBA 10/2015 - 03/2014
4	Analgesics (Analgesic Drugs)IBA 02/2014 - 01/2012
4	Reverse Transcriptase InhibitorsIBA 10/2005 - 09/2003
4	NucleosidesIBA 10/2005 - 09/2003
3	quinolineIBA 02/2016 - 10/2005
3	Glutamic Acid (Glutamate)FDA Link 11/2015 - 08/2009
3	Ciprofloxacin (Cipro)FDA LinkGeneric 04/2014 - 08/2004
3	Carboxylic AcidsIBA 01/2009 - 10/2005
3	QuinolonesIBA 02/2008 - 10/2005
3	Anticonvulsants (Antiepileptic Drugs)IBA 05/2007 - 05/2006
3	SemicarbazonesIBA 05/2007 - 08/2004
3	IsatinIBA 10/2005 - 11/2004
2	LigandsIBA 01/2022 - 10/2015
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2021 - 08/2013
2	Amino Acids FDA Link 03/2016 - 03/2004
2	Biological ProductsIBA 03/2016 - 10/2015
2	Topoisomerase II InhibitorsIBA 02/2016 - 10/2005
2	resazurinIBA 01/2016 - 10/2005
2	Alanine DehydrogenaseIBA 01/2016 - 02/2014
2	Acetic Acid (Vinegar)FDA LinkGeneric 11/2015 - 05/2007
2	NAD (NADH)IBA 10/2015 - 07/2014
2	ThiadiazolesIBA 05/2015 - 12/2012
2	Peptide Hydrolases (Proteases)FDA Link 02/2015 - 04/2013
2	Peptides (Polypeptides)IBA 02/2015 - 04/2013
2	Ethambutol (Myambutol)FDA LinkGeneric 04/2014 - 08/2004
2	ThiophenesIBA 04/2014 - 04/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2012 - 12/2012
2	ProdrugsIBA 06/2012 - 03/2004
2	Isoniazid (Ftivazide)FDA LinkGeneric 01/2009 - 10/2005
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022
1	CytokinesIBA 08/2021
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2019
1	Polysaccharides (Glycans)IBA 03/2018
1	LipopolysaccharidesIBA 03/2018
1	myelin oligodendrocyte glycoprotein (35-55)IBA 01/2017
1	APTIBA 12/2016
1	Cathepsin DIBA 05/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2016
1	AmidesIBA 03/2016
1	Deoxycholic Acid (Sodium Deoxycholate)IBA 03/2016
1	Bile Acids and Salts (Bile Acids)IBA 03/2016
1	Cisplatin (Platino)FDA LinkGeneric 03/2016
1	benzothiazoleIBA 03/2016
1	Cholic AcidIBA 03/2016
1	AcridinesIBA 02/2016
1	DiaminesIBA 02/2016
1	CarrageenanIBA 01/2016
1	PiperazineIBA 01/2016
1	Phosphotransferases (Kinase)IBA 01/2016
1	1,3,4-thiadiazoleIBA 01/2016
1	ThioureaIBA 01/2016
1	Lysine (L-Lysine)FDA Link 12/2015
1	Transaminases (Aminotransferases)IBA 12/2015
1	Capsaicin (Zostrix)FDA Link 11/2015
1	Formaldehyde (Formol)FDA Link 11/2015
1	PKC-3 proteinIBA 10/2015
1	Uridine Diphosphate (UDP)IBA 10/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2015
1	N-acetylglucosamine-1-phosphateIBA 10/2015

Therapy/Procedure

5	Therapeutics 05/2016 - 09/2003
5	Ligation 02/2014 - 05/2007